Tioga Pharmaceuticals Gets $10M

San Diego-based Tioga Pharmaceuticals, a developer of biopharmaceuticals for treating irritable bowel syndrome, said today that it has raised $10M in a Series B funding round. The round was led by Thomas, McNerney & Partners, which also included Genesys Capital Partners. Tioga said Thomas, NcNerney & Partners' Jason Brown takes a seat on its board with the funding. Tioga will use the new funding round for Phase 3 clinical development of its compound for treating irritable bowel syndrome (D-IBS). More information »